Lilly’s $7.8 Billion Bet Takes It Beyond Obesity Into Sleep

Published on April 1, 2026

Eli Lilly & Co.’s Zepbound is helping to solve one of the most intractable health challenges of our time: Obesity. Now, the drugmaker hopes to crack another significant public health problem: Sleep disorders.

Continue reading on website
Other news

OpenAI Valued at $852 Billion After Completing $122 Billion Round

April 1, 2026
OpenAI has completed a deal to raise $122 billion from investors at an $852 billion valuation, marking the company’s largest funding round to date by far and bolstering its costly push for more chips, data centers and talent.

Billionaire Nelson Peltz Plans AI Makeover for Janus Henderson

April 1, 2026
Now that Nelson Peltz has won a surprise bidding war for Janus Henderson Group Plc, the activist investor can start to revamp the $493 billion asset manager he has circled for years.